HNSPF
Price
$4.58
Change
-$0.62 (-11.92%)
Updated
Aug 25 closing price
Capitalization
28.29B
SBFM
Price
$1.35
Change
-$0.07 (-4.90%)
Updated
Sep 5 closing price
Capitalization
6.17M
64 days until earnings call
Interact to see
Advertisement

HNSPF vs SBFM

Header iconHNSPF vs SBFM Comparison
Open Charts HNSPF vs SBFMBanner chart's image
Hansoh Pharmaceutical Group
Price$4.58
Change-$0.62 (-11.92%)
Volume$800
Capitalization28.29B
Sunshine Biopharma
Price$1.35
Change-$0.07 (-4.90%)
Volume$70.09K
Capitalization6.17M
HNSPF vs SBFM Comparison Chart in %
Loading...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HNSPF vs. SBFM commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and SBFM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (HNSPF: $4.58 vs. SBFM: $1.36)
Brand notoriety: HNSPF and SBFM are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HNSPF: 85% vs. SBFM: 62%
Market capitalization -- HNSPF: $28.29B vs. SBFM: $6.17M
HNSPF [@Pharmaceuticals: Generic] is valued at $28.29B. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $6.17M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 2 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • HNSPF’s FA Score: 2 green, 3 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, HNSPF is a better buy in the long-term than SBFM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSPF’s TA Score shows that 3 TA indicator(s) are bullish while SBFM’s TA Score has 3 bullish TA indicator(s).

  • HNSPF’s TA Score: 3 bullish, 3 bearish.
  • SBFM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HNSPF is a better buy in the short-term than SBFM.

Price Growth

HNSPF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was -5.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

SBFM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($28.3B) has a higher market cap than SBFM($6.17M). HNSPF has higher P/E ratio than SBFM: HNSPF (40.89) vs SBFM (0.00). HNSPF YTD gains are higher at: 114.701 vs. SBFM (-54.833).
HNSPFSBFMHNSPF / SBFM
Capitalization28.3B6.17M458,448%
EBITDAN/A-6.19M-
Gain YTD114.701-54.833-209%
P/E Ratio40.890.004,060,827%
RevenueN/A36.3M-
Total CashN/A10.3M-
Total DebtN/A929K-
FUNDAMENTALS RATINGS
SBFM: Fundamental Ratings
SBFM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HNSPFSBFM
RSI
ODDS (%)
Bearish Trend 4 days ago
25%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
40%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
13%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
28%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
26%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
90%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPID2.720.28
+11.48%
Rapid Micro Biosystems
NEXN9.880.14
+1.44%
Nexxen International Ltd
RL312.02-8.73
-2.72%
Ralph Lauren Corp
EXTR21.70-0.75
-3.34%
Extreme Networks
BGLC5.04-0.65
-11.42%
Bionexus Gene Lab Corp

HNSPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSPF has been loosely correlated with SBFM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSPF jumps, then SBFM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
SBFM - HNSPF
46%
Loosely correlated
-5.24%
GEDSF - HNSPF
33%
Loosely correlated
N/A
TSMRF - HNSPF
29%
Poorly correlated
N/A
ACB - HNSPF
27%
Poorly correlated
+1.66%
OGI - HNSPF
23%
Poorly correlated
+2.48%
More

SBFM and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBFM has been loosely correlated with HNSPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SBFM jumps, then HNSPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-5.24%
HNSPF - SBFM
46%
Loosely correlated
N/A
CHSYF - SBFM
30%
Poorly correlated
N/A
ELAN - SBFM
27%
Poorly correlated
+5.50%
TLRY - SBFM
27%
Poorly correlated
+3.48%
EVOK - SBFM
25%
Poorly correlated
-1.51%
More